Prof. Dr. Marc Hübner
Institute for Medical Microbiology, Immunology and Parasitology
huebner@uni-bonn.de View member: Prof. Dr. Marc HübnerPublication categories: Top publication
Immunity
Human toll-like receptor 8 (TLR8) activation induces a potent T helper-1 (Th1) cell response critical for defense against intracellular pathogens, including protozoa. The receptor harbors two distinct binding sites, uridine and di- and/or trinucleotides, but the RNases upstream of TLR8 remain poorly characterized. We identified two endolysosomal endoribonucleases, RNase T2 and RNase 2, that act synergistically to release uridine from oligoribonucleotides. RNase T2 cleaves preferentially before, and RNase 2 after, uridines. Live bacteria, P. falciparum-infected red blood cells, purified pathogen RNA, and synthetic oligoribonucleotides all required RNase 2 and T2 processing to activate TLR8. Uridine supplementation restored RNA recognition in RNASE2 or RNASET2 but not RNASE2RNASET2 cells. Primary immune cells from RNase T2-hypomorphic patients lacked a response to bacterial RNA but responded robustly to small-molecule TLR8 ligands. Our data identify an essential function of RNase T2 and RNase 2 upstream of TLR8 and provide insight into TLR8 activation.
Copyright © 2020 Elsevier Inc. All rights reserved.
PMID: 32294405
Institute for Medical Microbiology, Immunology and Parasitology
huebner@uni-bonn.de View member: Prof. Dr. Marc HübnerMedical Microbiology, Immunology and Parasitology
achim.hoerauf@ukbonn.de View member: Prof. Dr. med. Achim HöraufInstitute of Clinical Chemistry & Clinical Pharmacology
winfried.barchet@uni-bonn.de View member: Prof. Dr. Winfried BarchetInstitute of Clinical Chemistry & Clinical Pharmacology
martin.schlee@uni-bonn.de View member: Prof. Dr. Martin SchleeInstitute of Clinical Chemistry & Clinical Pharmacology
gunther.hartmann@ukbonn.de View member: Prof. Dr. med. Gunther HartmannInstitute for Experimental Hematology and Transfusion Medicine
ebartok@uni-bonn.de View member: Prof. Dr. Eva Bartok